Corrigendum: Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential

Frontiers in Physiology

Physiology

Clemens Steegborn¹  Jochen Buck²  Lonny R. Levin²  Jacob Ferreira²  Lubna Ghanem²  Hannes Buck²  Thomas Rossetti²  Robert W. Myers³  Peter T. Meinke³ 

[1] Department of Biochemistry, University of Bayreuth, Bayreuth, Germany;Department of Pharmacology, Weill Cornell Medicine, New York, NY, United States;Tri-Institutional Therapeutics Discovery Institute, New York, NY, United States;

关键词: soluble adenylyl cyclase;    male contraceptive;    residence time;    drug development;    picomolar potency;    binding kinetics;    lead optimization;    SPR;   

DOI  :  10.3389/fphys.2023.1163389

 received in 2023-02-10, accepted in 2023-02-21,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Rossetti, Ferreira, Ghanem, Buck, Steegborn, Myers, Meinke, Levin and Buck.

【 图 表 】

fpsyg-14-1232357-i002.tif

FPHYS_fphys-2023-1163389_wc_tfx5.tif

FMATS_fmats-2023-1230097_wc_tfx14.tif

FMATS_fmats-2023-1230097_wc_tfx13.tif

fdmed-04-1120394-i005.tif

FENRG_fenrg-2023-1121853_wc_tfx2.tif